Actuate Therapeutics Files Definitive Proxy Statement
Ticker: ACTU · Form: DEF 14A · Filed: Apr 8, 2025 · CIK: 1652935
| Field | Detail |
|---|---|
| Company | Actuate Therapeutics, Inc. (ACTU) |
| Form Type | DEF 14A |
| Filed Date | Apr 8, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, annual-meeting, corporate-governance
TL;DR
Actuate Therapeutics DEF 14A filed - proxy materials for May 22 meeting are out.
AI Summary
Actuate Therapeutics, Inc. filed its definitive proxy statement on April 8, 2025, for its annual meeting on May 22, 2025. The company, formerly known as Apotheca Therapeutics, Inc. until September 11, 2015, is seeking shareholder approval for matters related to corporate governance and executive compensation. The filing details the company's business address in Fort Worth, Texas, and its fiscal year end of December 31.
Why It Matters
This filing provides shareholders with crucial information regarding upcoming votes on company leadership and policies, enabling informed participation in corporate governance.
Risk Assessment
Risk Level: low — This is a routine proxy filing and does not contain new financial information or significant corporate events.
Key Players & Entities
- ACTUATE THERAPEUTICS, INC. (company) — Registrant
- Apotheca Therapeutics, Inc. (company) — Former company name
- May 22, 2025 (date) — Annual meeting date
- April 8, 2025 (date) — Filing date
- Fort Worth, Texas (location) — Company business address
FAQ
What is the purpose of this DEF 14A filing?
The purpose of this DEF 14A filing is to provide shareholders with the definitive proxy statement for Actuate Therapeutics, Inc.'s annual meeting of shareholders scheduled for May 22, 2025.
When was Actuate Therapeutics, Inc. formerly known as?
Actuate Therapeutics, Inc. was formerly known as Apotheca Therapeutics, Inc. until September 11, 2015.
Where is Actuate Therapeutics, Inc. located?
Actuate Therapeutics, Inc.'s business address is 1751 River Run, Suite 400, Fort Worth, TX 76107.
What is the fiscal year end for Actuate Therapeutics, Inc.?
The fiscal year end for Actuate Therapeutics, Inc. is December 31.
What is the SEC file number for Actuate Therapeutics, Inc.?
The SEC file number for Actuate Therapeutics, Inc. is 001-42139.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 8, 2025 regarding ACTUATE THERAPEUTICS, INC. (ACTU).